EVLVW vs TMO · rev $29.1M vs P/E 24, rev $23.00B
Evolv Technologies Holdings Inc (EVLVW) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Evolv Technologies Holdings Inc (EVLVW) common stock listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported EVLVW revenue for 2024-12-31 was $29.1M. Net income was -$15.7M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. EVLVW currently screens at market cap $0.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
EVLVW currently screens at market cap $0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the EVLVW and TMO stock pages for the full models.
Not investment advice.